Cargando…
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
With the increasing number of medications demonstrating mortality benefits in heart failure with reduced ejection fraction (HFrEF), the pharmacological treatment of HFrEF is entering a new phase. To enhance outcomes in heart failure patients through medical treatment, the choice of appropriate medic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Internal Medicine
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493440/ https://www.ncbi.nlm.nih.gov/pubmed/37680097 http://dx.doi.org/10.3904/kjim.2023.223 |